c‑Jun N‑terminal kinase‑mediated anti‑inflammatory effects of Garcinia subelliptica in macrophages

Cho,Young‑Chang; Cho,Sayeon

doi:10.3892/mmr.2016.4791

c‑Jun N‑terminal kinase‑mediated anti‑inflammatory effects of Garcinia subelliptica in macrophages

Authors:
- Young‑Chang Cho
- Sayeon Cho
View Affiliations

Affiliations: Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung‑Ang University, Seoul 156‑756, Republic of Korea
Published online on: January 18, 2016 https://doi.org/10.3892/mmr.2016.4791
Pages: 2293-2300

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Garcinia plants have been traditionally used to treat inflammatory diseases, such as skin infections and pain, in many regions including South‑East Asia. Garcinia subelliptica, a plant of the Garcinia species widely distributed from Japan to Thailand, has been reported to contain components similar to other Garcinia plants that exhibit anti‑inflammatory effects. The present study aimed to explore the anti‑inflammatory effects of ethanol extracts of Garcinia subelliptica (EGS) in macrophages, as there are no previous systemic studies that have investigated the effects of Garcinia subelliptica on inflammation. Non‑cytotoxic concentrations of EGS (≤200 µg/ml) were observed to reduce nitric oxide production by modulating iNOS expression in lipopolysaccharide (LPS)‑stimulated RAW 264.7 macrophages. The expression of cyclooxygenase‑2, the enzyme responsible for the production of prostaglandin E2, was notably reduced by EGS. EGS treatment inhibited the production of pro‑inflammatory cytokines, including IL‑6 and IL‑1β, however, not TNF‑α. Reduced production of inflammatory mediators by EGS was followed by reduced phosphorylation of c‑Jun N‑terminal kinase (JNK) however, not of other mitogen‑activated protein kinases and nuclear factor‑κB. These results indicate that EGS selectively inhibits the excessive production of inflammatory mediators in LPS‑stimulated murine macrophages by reducing the activation of JNK, suggesting that EGS is a candidate for modulating severe inflammation.

View Figures

View References

1	Boscá L, Zeini M, Través PG and Hortelano S: Nitric oxide and cell viability in inflammatory cells: A role for NO in macrophage function and fate. Toxicology. 208:249–258. 2005. View Article : Google Scholar : PubMed/NCBI
2	Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H and Ikeda H: Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: Roles of the receptor complex. Pharmacol Ther. 100:171–194. 2003. View Article : Google Scholar : PubMed/NCBI
3	Fujiwara N and Kobayashi K: Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 4:281–286. 2005. View Article : Google Scholar : PubMed/NCBI
4	MacMicking J, Xie QW and Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol. 15:323–350. 1997. View Article : Google Scholar : PubMed/NCBI
5	Jones BW, Heldwein KA, Means TK, Saukkonen JJ and Fenton MJ: Differential roles of toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis. 60(Suppl 3): iii6–iii12. 2001.
6	Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT and Fenton MJ: Different toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol. 69:1036–1044. 2001.PubMed/NCBI
7	Rhee SH and Hwang D: Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem. 275:34035–34040. 2000. View Article : Google Scholar : PubMed/NCBI
8	Schroder K, Sweet MJ and Hume DA: Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology. 211:511–524. 2006. View Article : Google Scholar : PubMed/NCBI
9	Stalińska K, Guzdek A, Rokicki M and Koj A: Transcription factors as targets of the anti-inflammatory treatment. A cell culture study with extracts from some mediterranean diet plants. J Physiol Pharmacol. 56(Suppl 1): S157–S169. 2005.
10	Szabó C and Thiemermann C: Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv Pharmacol. 34:113–153. 1995. View Article : Google Scholar : PubMed/NCBI
11	Clancy RM, Amin AR and Abramson SB: The role of nitric oxide in inflammation and immunity. Arthritis Rheumatol. 41:1141–1151. 1998. View Article : Google Scholar
12	Guadagni F, Ferroni P, Palmirotta R, Portarena I, Formica V and Roselli M: Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: An early target in anticancer therapeutic strategy. In Vivo. 21:147–161. 2007.PubMed/NCBI
13	Kröncke KD, Fehsel K and Kolb-Bachofen V: Inducible nitric oxide synthase in human diseases. Clin Exp Immunol. 113:147–156. 1998. View Article : Google Scholar : PubMed/NCBI
14	Nathan C and Xie QW: Nitric oxide synthases: Roles, tolls and controls. Cell. 78:915–918. 1994. View Article : Google Scholar : PubMed/NCBI
15	Nathan C and Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem. 269:13725–13728. 1994.PubMed/NCBI
16	Nishimoto N and Kishimoto T: Interleukin 6: From bench to bedside. Nat Clin Pract Rheumatol. 2:619–626. 2006. View Article : Google Scholar : PubMed/NCBI
17	Calixto JB: Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res. 33:179–189. 2000. View Article : Google Scholar : PubMed/NCBI
18	Wutthithamavet W: Thai traditional medicine. revised edition. Odean Store Press; Bangkok: 1997
19	Tewtrakul S, Wattanapiromsakul C and Mahabusarakam W: Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells. J Ethnopharmacol. 121:379–382. 2009. View Article : Google Scholar
20	Cui J, Hu W, Cai Z, Liu Y, Li S, Tao W and Xiang H: New medicinal properties of mangostins: Analgesic activity and pharmacological characterization of active ingredients from the fruit hull of Garcinia mangostana L. Pharmacol Biochem Behav. 95:166–172. 2010. View Article : Google Scholar : PubMed/NCBI
21	Duke JA: Handbook of medical herbs. Library of congress; New York: 1985
22	Evan WC: Trease and Evans pharmacognosy. Saunders Company Limited; Nottingham: 1996
23	Panthong A, Norkaew P, Kanjanapothi D, Taesotikul T, Anantachoke N and Reutrakul V: Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook f. J Ethnopharmacol. 111:335–340. 2007. View Article : Google Scholar : PubMed/NCBI
24	Guimarães CL, Otuki MF, Beirith A and Cabrini DA: A review on the therapeutic potential of Garcinia gardneriana. Dynamis. 12:6–12. 2004.In Portuguese.
25	Castardo JC, Prudente AS, Ferreira J, Guimarães CL, Monache FD, Filho VC, Otuki MF and Cabrini DA: Anti-inflammatory effects of hydroalcoholic extract and two biflavonoids from Garcinia gardneriana leaves in mouse paw oedema. J Ethnopharmacol. 118:405–411. 2008. View Article : Google Scholar : PubMed/NCBI
26	Ayepola OR, Chegou NN, Brooks NL and Oguntibeju OO: Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses. BMC Complement Altern Med. 13:3632013. View Article : Google Scholar : PubMed/NCBI
27	Farombi EO, Adedara IA, Ajayi BO, Ayepola OR and Egbeme EE: Kolaviron, a natural antioxidant and anti-inflammatory phyto-chemical prevents dextran sulphate sodium-induced colitis in rats. Basic Clin Pharmacol Toxicol. 113:49–55. 2013. View Article : Google Scholar : PubMed/NCBI
28	Li F, Shanmugam MK, Chen L, Chatterjee S, Basha J, Kumar AP, Kundu TK and Sethi G: Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer Prev Res (Phila). 6:843–854. 2013. View Article : Google Scholar
29	Tsai ML, Chiou YS, Chiou LY, Ho CT and Pan MH: Garcinol suppresses inflammation-associated colon carcinogenesis in mice. Mol Nutr Food Res. 58:1820–1829. 2014. View Article : Google Scholar : PubMed/NCBI
30	Minami H, Takahashi E, Fukuyama Y, Kodama M, Yoshizawa T and Nakagawa K: Novel xanthones with superoxide scavenging activity from Garcinia subelliptica. Chem Pharm Bull (Tokyo). 43:347–349. 1995. View Article : Google Scholar
31	Minami H, Hamaguchi K, Kubo M and Fukuyama Y: A benzophenone and a xanthone from Garcinia subelliptica. Phytochemistry. 49:1783–1785. 1998. View Article : Google Scholar
32	Ito T, Yokota R, Watarai T, Mori K, Oyama M, Nagasawa H, Matsuda H and Iinuma M: Isolation of six isoprenylated biflavonoids from the leaves of Garcinia subelliptica. Chem Pharm Bull (Tokyo). 61:551–558. 2013. View Article : Google Scholar
33	Weng JR, Tsao LT, Wang JP, Wu RR and Lin CN: Anti-inflammatory phloroglucinols and terpenoids from Garcinia subelliptica. J Nat Prod. 67:1796–1799. 2004. View Article : Google Scholar : PubMed/NCBI
34	Weng JR, Lin CN, Tsao LT and Wang JP: Terpenoids with a new skeleton and novel triterpenoids with anti-inflammatory effects from Garcinia subelliptica. Chemistry. 9:5520–5527. 2003. View Article : Google Scholar : PubMed/NCBI
35	Weng JR, Lin CN, Tsao LT and Wang JP: Novel and anti-inflammatory constituents of Garcinia subelliptica. Chemistry. 9:1958–1963. 2003. View Article : Google Scholar : PubMed/NCBI
36	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
37	Koressaar T and Remm M: Enhancements and modifications of primer design program Primer3. Bioinformatics. 23:1289–91. 2007. View Article : Google Scholar : PubMed/NCBI
38	Samavati L, Rastogi R, Du W, Hüttemann M, Fite A and Franchi L: STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol. 46:1867–1877. 2009. View Article : Google Scholar : PubMed/NCBI
39	Zhu ZG, Jin H, Yu PJ, Tian YX, Zhang JJ and Wu SG: Mollugin Inhibits the inflammatory response in lipopolysaccharide-stimulated RAW264.7 macrophages by blocking the Janus kinase-signal transducers and activators of transcription signaling pathway. Biol Pharm Bull. 36:399–406. 2013. View Article : Google Scholar : PubMed/NCBI
40	Lee C, Lim HK, Sakong J, Lee YS, Kim JR and Baek SH: Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production. Mol Pharmacol. 69:1041–1047. 2006.
41	Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC and Podolsky DK: Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J Immunol. 164:966–972. 2000. View Article : Google Scholar : PubMed/NCBI
42	Burk DR, Senechal-Willis P, Lopez LC, Hogue BG and Daskalova SM: Suppression of lipopolysaccharide-induced inflammatory responses in RAW 264.7 murine macrophages by aqueous extract of Clinopodium vulgare L. (Lamiaceae). J Ethnopharmacol. 126:397–405. 2009. View Article : Google Scholar : PubMed/NCBI
43	Liu H, Bargouti M, Zughaier S, Zheng Z, Liu Y, Sangadala S, Boden SD and Titus L: Osteoinductive LIM mineralization protein-1 suppresses activation of NF-kappaB and selectively regulates MAPK pathways in pre-osteoclasts. Bone. 46:1328–1335. 2010. View Article : Google Scholar :
44	Shan J, Fu J, Zhao Z, Kong X, Huang H, Luo L and Yin Z: Chlorogenic acid inhibits lipopolysaccharide-induced cyclo-oxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation. Int Immunopharmacol. 9:1042–1048. 2009. View Article : Google Scholar : PubMed/NCBI
45	Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN and Bertics PJ: A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: The MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J Biol Chem. 277:9077–9087. 2002. View Article : Google Scholar : PubMed/NCBI
46	Caivano M: Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett. 429:249–253. 1998. View Article : Google Scholar : PubMed/NCBI
47	Paul A, Cuenda A, Bryant CE, Murray J, Chilvers ER, Cohen P, Gould GW and Plevin R: Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell Signal. 11:491–497. 1999. View Article : Google Scholar : PubMed/NCBI